NO328807B1 - Nytt suksinatsalt av O-desmetyl-venlafaxine, fremgangsmate for fremstilling av disse, farmasoytisk preparat omfattende slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom - Google Patents

Nytt suksinatsalt av O-desmetyl-venlafaxine, fremgangsmate for fremstilling av disse, farmasoytisk preparat omfattende slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom Download PDF

Info

Publication number: NO328807B1
Authority: NO; Norway
Prior art keywords: venlafaxine; desmethyl; succinate; monosuccinate; compound according
Prior art date: 2001-02-12

Application number

NO20033538A

Other languages

English (en)

Norwegian (no)

Other versions

NO20033538L (no

NO20033538D0 (no

Inventor

Beat Theodor Weber

Anthony Francis Hadfield

Syed Muzafar Shah

Michael William Winkley

Karen Wiggins Sutherland

James Andrew Provost

Aeri Park

Rex Alwyn Shipplet

Brenton William Russell

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-12

Filing date

2003-08-11

Publication date

2010-05-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26952945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO328807(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-08-11 Application filed by Wyeth Corp filed Critical Wyeth Corp

2003-08-11 Publication of NO20033538L publication Critical patent/NO20033538L/no

2003-08-11 Publication of NO20033538D0 publication Critical patent/NO20033538D0/no

2010-05-18 Publication of NO328807B1 publication Critical patent/NO328807B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Physical Education & Sports Medicine (AREA)
Anesthesiology (AREA)
Gynecology & Obstetrics (AREA)
Obesity (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Psychology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20033538A 2001-02-12 2003-08-11 Nytt suksinatsalt av O-desmetyl-venlafaxine, fremgangsmate for fremstilling av disse, farmasoytisk preparat omfattende slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom NO328807B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US26821401P	2001-02-12	2001-02-12
US29796301P	2001-06-13	2001-06-13
PCT/US2002/004103 WO2002064543A2 (en)	2001-02-12	2002-02-11	Novel succinate salt of o-desmethyl-venlafaxine

Publications (3)

Publication Number	Publication Date
NO20033538L NO20033538L (no)	2003-08-11
NO20033538D0 NO20033538D0 (no)	2003-08-11
NO328807B1 true NO328807B1 (no)	2010-05-18

Family

ID=26952945

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033538A NO328807B1 (no)	2001-02-12	2003-08-11	Nytt suksinatsalt av O-desmetyl-venlafaxine, fremgangsmate for fremstilling av disse, farmasoytisk preparat omfattende slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom

Country Status (30)

Country	Link
US (5)	US6673838B2 (es)
EP (3)	EP1360169B2 (es)
JP (1)	JP4220243B2 (es)
KR (1)	KR100875610B1 (es)
CN (2)	CN100567253C (es)
AR (2)	AR032671A1 (es)
AT (1)	ATE369330T1 (es)
AU (1)	AU2002250058B2 (es)
BR (1)	BR0207157A (es)
CA (2)	CA2666611A1 (es)
CY (1)	CY1106952T1 (es)
DE (1)	DE60221642T3 (es)
DK (1)	DK1360169T3 (es)
EA (1)	EA011451B1 (es)
ES (1)	ES2290281T5 (es)
HN (1)	HN2002000030A (es)
HU (1)	HUP0303128A3 (es)
IL (4)	IL157340A0 (es)
MX (1)	MXPA03007043A (es)
NO (1)	NO328807B1 (es)
NZ (1)	NZ539791A (es)
PA (1)	PA8539901A1 (es)
PE (1)	PE20020877A1 (es)
PL (2)	PL211788B1 (es)
PT (1)	PT1360169E (es)
SI (1)	SI1360169T1 (es)
TW (1)	TWI318201B (es)
UY (1)	UY27175A1 (es)
WO (1)	WO2002064543A2 (es)
ZA (1)	ZA200307116B (es)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20010075419A (ko)	1998-10-30	2001-08-09	에가시라 구니오	안정성이 우수한 아스파르탐 유도체 결정의 결정 석출법
US6342533B1 (en)	1998-12-01	2002-01-29	Sepracor, Inc.	Derivatives of (−)-venlafaxine and methods of preparing and using the same
CZ20013607A3 (cs) *	1999-04-06	2002-06-12	Sepracor Inc.	Farmaceutický prostředek
HN2002000030A (es) *	2001-02-12	2004-06-07	Wyeth Corp	Nueva sal succinato de o-desmetil-venlafaxina
US20050244498A1 (en) *	2001-09-14	2005-11-03	Biovail Laboratories, Inc.	Modified-release compositions of at least one form of venlafaxine
UA80543C2 (en)	2001-12-04	2007-10-10	Wyeth Corp	Method for the preparation of o-desmethylvenlafaxine
WO2003082261A1 (en) *	2002-03-28	2003-10-09	Synthon B.V.	Extended release venlafaxine formulations
KR20050013125A (ko) *	2002-06-10	2005-02-02	와이어쓰	Ｏ-데스메틸-벤라팍신의 신규한 포르메이트 염
WO2004019948A1 (en) *	2002-08-29	2004-03-11	Arachnova Therapeutics Ltd.	New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno[2,3-d]pyrimidine
US7345096B2 (en) *	2002-10-15	2008-03-18	Wyeth	Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7429565B2 (en)	2003-04-25	2008-09-30	Gilead Sciences, Inc.	Antiviral phosphonate analogs
JP2004359665A (ja) *	2003-05-30	2004-12-24	Rohm & Haas Co	生体利用性増強剤を含有する治療組成物
US7402698B2 (en)	2003-10-14	2008-07-22	Wyeth	Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7524846B2 (en)	2003-10-14	2009-04-28	Wyeth	Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US7491723B2 (en)	2003-10-14	2009-02-17	Wyeth	Alkanol and cycloalkanol-amine derivatives and methods of their use
US7365076B2 (en)	2003-10-14	2008-04-29	Wyeth	Substituted aryl cycloalkanol derivatives and methods of their use
US7550485B2 (en)	2003-10-14	2009-06-23	Wyeth	Substituted N-heterocycle derivatives and methods of their use
US7419980B2 (en)	2003-10-14	2008-09-02	Wyeth	Fused-aryl and heteroaryl derivatives and methods of their use
US7531543B2 (en)	2003-10-14	2009-05-12	Wyeth	Phenylpiperazine cycloalkanol derivatives and methods of their use
KR20060132891A (ko) *	2004-02-06	2006-12-22	와이어쓰	다중미립자 ｏ－데스메틸벤라팍신 염 및 그의 용도
US7414052B2 (en)	2004-03-30	2008-08-19	Wyeth	Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en)	2004-03-30	2009-04-14	Wyeth	Phenylaminopropanol derivatives and methods of their use
US7439280B2 (en) *	2004-04-06	2008-10-21	Basf Corporation	Lignocellulosic composite material and method for preparing the same
JP2008507550A (ja) *	2004-07-22	2008-03-13	ワイス	神経系障害及び状態の処置方法
KR20070045278A (ko) *	2004-07-22	2007-05-02	와이어쓰	신경계 질환 및 장애의 치료 방법
MX2007000851A (es) *	2004-07-22	2007-03-26	Wyeth Corp	Procedimiento para el tratamiento de trastornos y dolencias del sistema nervioso.
HRP20070078A2 (hr)	2004-07-27	2007-05-31	Gilead Sciences	Fosfonatni analozi spojeva koji inhibiraju hiv
WO2006094083A1 (en) *	2005-02-28	2006-09-08	Penwest Pharmaceuticals Co.	Controlled release venlafaxine formulations
KR20070116607A (ko) *	2005-03-31	2007-12-10	와이어쓰	Ｏ-데스메틸벤라팍신 및 바제독시펜의 조합 산물 및 이의용도
CN1955159B (zh) *	2005-06-17	2010-11-24	山东绿叶制药有限公司	用于阻断5-羟色胺以及去甲基肾上腺素再摄取的化合物,其制备方法及其用途
MX2008000249A (es) *	2005-07-06	2008-03-18	Sepracor Inc	Combinaciones de eszopiclona y o-desmetilvenlafaxina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y cognitivos.
US7687520B2 (en) *	2005-07-15	2010-03-30	Wyeth Llc	Serotonin and norepinephrine reuptake inhibitors and uses thereof
RU2007149183A (ru) *	2005-07-15	2009-08-20	Вайет (Us)	Высокоселективный двойной ингибитор обратного захвата серотонина и норэпинефрина и его применение
US7595340B2 (en) *	2005-07-15	2009-09-29	Wyeth	Serotonin and norepinephrine reuptake inhibitor and uses thereof
CA2615474A1 (en) *	2005-07-21	2007-02-01	Wyeth	Method for treating nervous system disorders and conditions
GT200600397A (es) *	2005-09-07	2007-08-28		Formulas topicas conteniendo o-desmetil venlafaxina (odv) o sus sales
GT200600396A (es) *	2005-09-07	2007-04-23		Dispositivos para la aplicacion de medicamentos transdermicos conteniendo o-desmetil venlafaxina (odv) o sus sales
CN1332946C (zh) *	2005-10-21	2007-08-22	中国人民解放军军事医学科学院放射与辐射医学研究所	作用于中枢神经系统的前药
EP2998288B1 (en)	2005-12-01	2022-08-24	ACADIA Pharmaceuticals Inc.	Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
AU2006322057A1 (en) *	2005-12-05	2007-06-14	Wyeth	Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
EP1973866A1 (en)	2005-12-20	2008-10-01	Synthon B.V.	Process for making desvenlafaxine
JP2008546718A (ja)	2006-04-17	2008-12-25	テバファーマシューティカルインダストリーズリミティド	実質的に純粋なｏ−デスメチルベンラファキシン及びその調製方法。
MX2007016179A (es)	2006-04-17	2008-03-11	Teva Pharma	Formas cristalinas de o-desmetilvenlafaxina.
PT2020996E (pt) *	2006-05-16	2012-02-20	Gilead Sciences Inc	Método e composições para tratar neoplasias malignas hematológicas
CA2656166A1 (en) *	2006-07-26	2008-01-31	Teva Pharmaceutical Industries Ltd.	Processes for the synthesis of o-desmethylvenlafaxine
US20090137846A1 (en) *	2006-07-26	2009-05-28	Valerie Niddam-Hildesheim	Processes for the synthesis of O-Desmethylvenlafaxine
US20080221356A1 (en) *	2006-07-26	2008-09-11	Valerie Niddam-Hildesheim	Processes for the synthesis of O-desmethylvenlafaxine
JP2008546850A (ja) *	2006-07-26	2008-12-25	テバファーマシューティカルインダストリーズリミティド	Ｏ−デスメチルベンラファキシンの合成方法
US20090069601A1 (en) *	2006-07-26	2009-03-12	Valerie Niddam-Hildesheim	Processes for the synthesis of O-desmethylvenlafaxine
ES2334765B1 (es) *	2006-08-04	2010-12-20	Medichem, S.A.	Proceso mejorado para sintetizar la base libre de la desvenlafaxina ysales o solvatos de la misma.
US20100035994A1 (en) *	2006-08-08	2010-02-11	Gore Vinayak G	Novel hydrate form of o-desmethyl venlafaxine succinate
US20100063160A1 (en) *	2006-10-18	2010-03-11	Merck Development Centre Private Limited	Polymorphs of o-desmethyl venlafaxine succinate
RU2009112105A (ru) *	2006-10-25	2010-11-27	Вайет (Us)	Выделенные гидрокси- и n-оксидные метаболиты и производные о-дезметилвенлафаксина и способы лечения
CN101611029B (zh) *	2006-12-21	2014-09-10	辉瑞产品公司	2-((4-(1-甲基-4-(吡啶-4-基)-1h-吡唑-3-基)苯氧基)甲基)喹啉的琥珀酸盐
WO2009027766A2 (en) *	2006-12-22	2009-03-05	Medichem, S.A.	New crystalline solid forms of o-desvenlafaxine base
US7820716B2 (en) *	2007-01-08	2010-10-26	Mai De Ltd	Crystalline polymorphs of desvenlafaxine succinate and their preparations
AR064987A1 (es) *	2007-01-22	2009-05-06	Medichem Sa	Proceso mejorado para sintetizar desvenlafaxina como base libre y sales o solvatos de la misma
AU2008211711A1 (en) *	2007-01-31	2008-08-07	Generics [Uk] Limited	Process for the preparation of O-desmethyl venlafaxine
US20090005457A1 (en)	2007-02-21	2009-01-01	Michael Sizensky	Solid forms comprising (-)-O-desmethylvenlafaxine and uses thereof
WO2008110338A1 (en) *	2007-03-09	2008-09-18	Synthon B.V.	Polymorph of desvenlafaxine succinate
WO2008112313A2 (en) *	2007-03-14	2008-09-18	Teva Pharmaceutical Industries Ltd.	Processes for preparing solid states of o-desmethylvenlafaxine succinate
DK2125698T3 (en)	2007-03-15	2016-11-07	Auspex Pharmaceuticals Inc	Deuterated d9-VENLAFAXINE
US20090012182A1 (en) *	2007-06-15	2009-01-08	Alexandr Jegorov	Crystal forms of O-desmethylvenlafaxine succinate
CA2692738A1 (en) *	2007-07-12	2009-01-15	Dr. Reddy's Laboratories, Ltd.	O-desmethylvenlafaxine
WO2009010990A2 (en) *	2007-07-16	2009-01-22	Matrix Laboratories Limited	Process for the preparation of o-desmethylvenlafaxine succinate polymorphic forms
WO2009017813A1 (en) *	2007-08-02	2009-02-05	Teva Pharmaceutical Industries Ltd.	O-desmethyl venlafaxine saccharinate
US20090076162A1 (en) *	2007-09-17	2009-03-19	Protia, Llc	Deuterium-enriched desvenlafaxine
US20100330172A1 (en) *	2007-10-16	2010-12-30	Alphapharm Pty Ltd	Controlled-release pharmaceutical formulation
EP2212275A2 (en) *	2007-10-22	2010-08-04	Actavis Group PTC EHF	Solid forms of (±)-o-desmethylvenlafaxine salts
CA2703647A1 (en)	2007-10-26	2009-04-30	Generics [Uk] Limited	Process for preparing o-desmethylvenlafaxine
US8063250B2 (en) *	2007-11-26	2011-11-22	Teva Pharmaceutical Industries, Ltd.	Crystal forms of O-desmethylvenlafaxine fumarate
EP2085377A1 (en) *	2008-01-29	2009-08-05	LEK Pharmaceuticals D.D.	Novel salts of O-desmethyl-venlafaxine
WO2009114685A2 (en) *	2008-03-12	2009-09-17	Dr. Reddy's Laboratories Ltd.	O-desmethylvenlafaxine salts
WO2009118758A2 (en) *	2008-03-24	2009-10-01	Sun Pharmaceutical Industries Ltd.	Novel crystalline forms of desvenlafaxine succinate
IN2008CH00818A (es) *	2008-04-01	2009-10-09	Actavis Group Ptc Ehf
KR100965527B1 (ko) *	2008-05-08	2010-06-23	제일약품주식회사	신규(4-(2-(디메틸아미노)-1-(1-하이드록시사이클로헥실)에틸)페녹시)포스페이트 또는 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계질환 예방 및 치료용 조성물
EP2119696A1 (en)	2008-05-16	2009-11-18	Krka	Preparation of O-desmethylvenlafaxine salts
EP2119695A1 (en) *	2008-05-16	2009-11-18	Krka	Preparation of O-desmethylvenlafaxine salts
EP2297087A2 (en) *	2008-06-16	2011-03-23	Teva Pharmaceutical Industries Ltd.	Solid states of o-desmethylvenlaf axine salts
PT2307435E (pt) *	2008-07-08	2012-09-19	Gilead Sciences Inc	Sais de compostos inibidores de vih
US20100016638A1 (en) *	2008-07-21	2010-01-21	Zdenko Hamersak	Method for preparation of o-desmethylvenlafaxine using polythiolates
US20110263718A1 (en) *	2008-07-30	2011-10-27	Generics [Uk] Limited	Process for the preparation of o-desmethylvenlafaxine
KR101041960B1 (ko) *	2008-08-14	2011-06-16	주식회사 루미맥스테크놀러지	파워 ｌｅｄ를 구비하는 램프 장치
EP2191822A1 (en)	2008-11-26	2010-06-02	LEK Pharmaceuticals d.d.	Controlled release pharmaceutical compositions comprising O-desmethyl-venlafaxine
CZ2008756A3 (cs) *	2008-11-27	2010-03-24	Zentiva, A. S.	Zpusob prípravy desvenlafaxinu a jeho solí
ES2343050B1 (es) *	2008-12-16	2011-06-14	Chemo Iberica, S.A.	Procedimiento para la preparacion de desvenlafaxina y sus sales de adicion de acido farmaceuticamente aceptables.
CZ200969A3 (cs) *	2009-02-06	2010-06-30	Zentiva, K.S.	Nové soli desvenlafaxinu a zpusob jejich prípravy
CZ2009454A3 (cs)	2009-07-15	2010-11-10	Zentiva, K. S.	Zpusob prípravy desvenlafaxinu a jeho solí
AU2010272377A1 (en)	2009-07-16	2012-01-19	Cipla Limited	Process for the preparation of O-desmethyl venlafaxine and intermediate for use therein
US20110098506A1 (en) *	2009-10-26	2011-04-28	Intas Pharmaceuticals Limited	Method of preparing o-desmethylvenlafaxine
US8754261B2 (en)	2009-12-16	2014-06-17	Pharmathen S.A.	Process for the preparation of O-desmethyl-venlafaxine and salts thereof
US20110184067A1 (en) *	2010-01-25	2011-07-28	Intas Pharmaceuticals Ltd.	O-desmethylvenlafaxine succinate polymorph & process for preparing thereof
CA2795023A1 (en)	2010-03-29	2011-10-06	Pliva Hrvatska D.O.O.	Crystal forms of o-desmethylvenlafaxine fumarate
WO2011121475A2 (en)	2010-03-31	2011-10-06	Wockhardt Limited	Modified release dosage form comprising desvenlafaxine or salts thereof
CZ303249B6 (cs)	2010-04-06	2012-06-20	Zentiva, K.S.	Zpusob výroby 4-(2-(substituovaných)-1-(1-hydroxycyklohexyl)ethyl)fenolu O-demethylací jejich methyletheru pomocí nepáchnoucích aromatických thiolu
CN102212014B (zh) *	2010-04-09	2013-12-25	江苏豪森医药集团有限公司	O-去甲基-文拉法辛的谷氨酸盐的晶型、其制备方法及其在医药上的应用
CA2788526A1 (en)	2010-05-14	2011-11-17	Alembic Limited	Extended release formulations of desvenlafaxine base
CN102249936B (zh) *	2010-05-19	2014-09-17	江苏豪森医药集团有限公司	O-去甲基文拉法辛盐酸盐的水合物及其制备方法
EP2621891B1 (en)	2010-10-01	2019-11-06	Shan Dong Luye Pharmaceutical Co., Ltd.	Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same
US8933123B2 (en)	2010-10-08	2015-01-13	Cadila Healthcare Limited	Polymorphic forms of O-desmethyl-venlafaxine succinate
EP2685966A1 (en)	2011-03-17	2014-01-22	Lupin Limited	Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
WO2012140577A1 (en)	2011-04-12	2012-10-18	Lupin Limited	Modified release pharmaceutical compositions of desvenlafaxine
US8481596B2 (en)	2011-06-08	2013-07-09	Lupin Limited	Polymomorph of desvenlafaxine benzoate
TW201422255A (zh) *	2012-10-24	2014-06-16	Onyx Therapeutics Inc	用於蛋白酶體抑制劑之調整釋放製劑
CN104666291A (zh) *	2013-11-26	2015-06-03	山东绿叶制药有限公司	去甲基文拉法辛苯甲酸酯类化合物在制备改善性功能障碍药物中的应用
CN104352469A (zh) *	2014-11-20	2015-02-18	哈尔滨圣吉药业股份有限公司	一种琥珀酸去甲文拉法辛缓释片及其制备方法
CN106146323B (zh) *	2015-04-03	2021-05-25	石药集团中奇制药技术（石家庄）有限公司	一种琥珀酸去甲文拉法辛一水合物新晶型及制备方法
MX367362B (es)	2016-06-29	2019-08-16	Alparis Sa De Cv	Nuevas formas solidas de desvenlafaxina.
WO2018146529A1 (en) *	2017-02-09	2018-08-16	R L Finechem Private Limited	A process for preparation of1-[2-(dimethylamino)-1-(4-hydroxyphenyl) ethyl]-cyclohexanol and salts thereof
CN107082745A (zh) *	2017-04-21	2017-08-22	上海华源医药科技发展有限公司	一种改进的ⅰ型去甲文拉法辛琥珀酸盐的生产方法
AU2018301395B2 (en) *	2017-07-11	2024-11-14	Universal Stabilization Technologies, Inc.	Method for Preserving Biological Materials
WO2019027920A1 (en)	2017-08-01	2019-02-07	Gilead Sciences, Inc.	CRYSTALLINE FORMS OF ETHYL ((S) - (((((2R, 5R) -5- (6-AMINO-9H-PURIN-9-YL) -4-FLUORO-2,5-DIHYDROFURAN-2-YL) OXY ) METHYL) (PHENOXY) PHOSPHORYL) -L-ALANINATE (GS-9131) FOR THE TREATMENT OF VIRAL INFECTIONS
TWI805601B (zh)	2017-08-11	2023-06-21	南韓商愛茉莉太平洋股份有限公司	醫藥組成物及抑制其形成結晶的方法
KR102518632B1 (ko)	2018-04-18	2023-04-06	(주)아모레퍼시픽	(r)-n-[1-(3,5-다이플루오로-4-메테인설폰일아미노-페닐)-에틸]-3-(2-프로필-6-트라이플루오로메틸-피리딘-3-일)-아크릴아마이드를 함유하는 약학 조성물
TR201820634A2 (tr)	2018-12-27	2020-07-21	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Desvenlafaksi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3536809A (en)	1969-02-17	1970-10-27	Alza Corp	Medication method
US3598123A (en)	1969-04-01	1971-08-10	Alza Corp	Bandage for administering drugs
US3845770A (en)	1972-06-05	1974-11-05	Alza Corp	Osmatic dispensing device for releasing beneficial agent
US3916899A (en)	1973-04-25	1975-11-04	Alza Corp	Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en)	1976-02-02	1977-02-22	Alza Corporation	Osmotic system having laminar arrangement for programming delivery of active agent
US4535186A (en)	1983-04-19	1985-08-13	American Home Products Corporation	2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
IE56324B1 (en) *	1982-12-13	1991-06-19	American Home Prod	Phenethylamine derivatives and intermediates therefor
US4761501A (en)	1983-10-26	1988-08-02	American Home Products Corporation	Substituted phenylacetamides
IE58110B1 (en)	1984-10-30	1993-07-14	Elan Corp Plc	Controlled release powder and process for its preparation
US5073543A (en)	1988-07-21	1991-12-17	G. D. Searle & Co.	Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
GB8902209D0 (en)	1989-02-01	1989-03-22	Wyeth John And Brother Limited	Preparation of cyclohexanol derivatives and novel thioamide intermediates
IT1229203B (it)	1989-03-22	1991-07-25	Bioresearch Spa	Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en)	1989-11-07	1992-06-09	Merck & Co., Inc.	Swelling modulated polymeric drug delivery device
US5733566A (en)	1990-05-15	1998-03-31	Alkermes Controlled Therapeutics Inc. Ii	Controlled release of antiparasitic agents in animals
US5580578A (en)	1992-01-27	1996-12-03	Euro-Celtique, S.A.	Controlled release formulations coated with aqueous dispersions of acrylic polymers
JPH07508281A (ja)	1992-06-23	1995-09-14	セプラコア　インコーポレーテッド	光学的に純粋な（＋）シブトラミンを用いるうつ病およびその他の障害を治療する方法ならびに組成物
CA2138998A1 (en)	1992-06-23	1994-01-06	James W. Young	Methods and compositions for treating depression and other disorders using optically pure(-) sibutramine
US5591767A (en)	1993-01-25	1997-01-07	Pharmetrix Corporation	Liquid reservoir transdermal patch for the administration of ketorolac
ES2304041T3 (es)	1993-06-28	2008-09-01	Wyeth	Nuevos tratamientos que utilizan derivados de fenetilamina.
TW344661B (en) *	1993-11-24	1998-11-11	Lilly Co Eli	Pharmaceutical composition for treatment of incontinence
DE69529109T2 (de) †	1994-02-14	2003-04-30	Wyeth, Madison	Venlafaxin und seine Analoga zum Herbeiführen einer Verbesserung der kognitiven Funktionen
US5594586A (en) *	1994-05-02	1997-01-14	The United States Of America As Represented By The Secretary Of The Air Force	Photorefractive limiting quadratic processor
IT1270594B (it)	1994-07-07	1997-05-07	Recordati Chem Pharm	Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5506270A (en) *	1995-01-30	1996-04-09	American Home Products Corporation	Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
US5554383A (en)	1995-04-06	1996-09-10	Trustees Of Tufts College	Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
US6274171B1 (en)	1996-03-25	2001-08-14	American Home Products Corporation	Extended release formulation of venlafaxine hydrochloride
EP0912577A2 (en) †	1996-05-21	1999-05-06	THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services	Novel methods of o-demethylation and n-deprotection
EP2042161A1 (en) †	1997-10-01	2009-04-01	Novadel Pharma Inc.	Propellant-free spray composition comprising anti-emetic agent
US6342533B1 (en)	1998-12-01	2002-01-29	Sepracor, Inc.	Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6197828B1 (en)	1998-12-01	2001-03-06	Sepracor, Inc.	Derivatives of (+)-venlafaxine and methods of preparing and using the same
CZ20013607A3 (cs)	1999-04-06	2002-06-12	Sepracor Inc.	Farmaceutický prostředek
WO2000072827A2 (en) †	1999-05-27	2000-12-07	Acusphere, Inc.	Porous drug matrices and methods of manufacture thereof
US20020022662A1 (en)	1999-06-15	2002-02-21	American Home Products Corporation	Enantiomers of O-desmethyl venlafaxine
AU5738700A (en) *	1999-06-15	2001-01-02	American Home Products Corporation	Enantiomers of o-desmethyl venlafaxine
HN2002000030A (es) *	2001-02-12	2004-06-07	Wyeth Corp	Nueva sal succinato de o-desmetil-venlafaxina
UA80543C2 (en) *	2001-12-04	2007-10-10	Wyeth Corp	Method for the preparation of o-desmethylvenlafaxine
KR20050013125A (ko)	2002-06-10	2005-02-02	와이어쓰	Ｏ-데스메틸-벤라팍신의 신규한 포르메이트 염
TWI306092B (en)	2003-03-11	2009-02-11	Wyeth Corp	Process for preparation of phenethylamine derivatives
KR20060132891A (ko)	2004-02-06	2006-12-22	와이어쓰	다중미립자 ｏ－데스메틸벤라팍신 염 및 그의 용도

2002
- 2002-02-11 HN HN2002000030A patent/HN2002000030A/es unknown
- 2002-02-11 NZ NZ539791A patent/NZ539791A/en not_active IP Right Cessation
- 2002-02-11 SI SI200230609T patent/SI1360169T1/sl unknown
- 2002-02-11 US US10/073,743 patent/US6673838B2/en not_active Expired - Lifetime
- 2002-02-11 CN CNB028081129A patent/CN100567253C/zh not_active Expired - Lifetime
- 2002-02-11 CA CA002666611A patent/CA2666611A1/en not_active Abandoned
- 2002-02-11 PE PE2002000105A patent/PE20020877A1/es active IP Right Grant
- 2002-02-11 EP EP02718949.7A patent/EP1360169B2/en not_active Expired - Lifetime
- 2002-02-11 PL PL364605A patent/PL211788B1/pl unknown
- 2002-02-11 CA CA002436668A patent/CA2436668C/en not_active Expired - Lifetime
- 2002-02-11 PT PT02718949T patent/PT1360169E/pt unknown
- 2002-02-11 JP JP2002564477A patent/JP4220243B2/ja not_active Expired - Lifetime
- 2002-02-11 HU HU0303128A patent/HUP0303128A3/hu unknown
- 2002-02-11 AT AT02718949T patent/ATE369330T1/de active
- 2002-02-11 DE DE60221642.7T patent/DE60221642T3/de not_active Expired - Lifetime
- 2002-02-11 EA EA200300873A patent/EA011451B1/ru not_active IP Right Cessation
- 2002-02-11 EP EP07014868A patent/EP1864967A1/en not_active Withdrawn
- 2002-02-11 ES ES02718949.7T patent/ES2290281T5/es not_active Expired - Lifetime
- 2002-02-11 BR BR0207157-6A patent/BR0207157A/pt not_active Application Discontinuation
- 2002-02-11 IL IL15734002A patent/IL157340A0/xx unknown
- 2002-02-11 KR KR1020037010561A patent/KR100875610B1/ko not_active Expired - Lifetime
- 2002-02-11 MX MXPA03007043A patent/MXPA03007043A/es active IP Right Grant
- 2002-02-11 WO PCT/US2002/004103 patent/WO2002064543A2/en not_active Ceased
- 2002-02-11 DK DK02718949T patent/DK1360169T3/da active
- 2002-02-11 PL PL396568A patent/PL212943B1/pl unknown
- 2002-02-11 EP EP10177304A patent/EP2319826A1/en not_active Withdrawn
- 2002-02-11 AU AU2002250058A patent/AU2002250058B2/en not_active Expired
- 2002-02-11 CN CN200910206182A patent/CN101671260A/zh active Pending
- 2002-02-12 AR ARP020100463A patent/AR032671A1/es not_active Application Discontinuation
- 2002-02-13 UY UY27175A patent/UY27175A1/es active IP Right Grant
- 2002-02-14 PA PA20028539901A patent/PA8539901A1/es unknown
- 2002-02-15 TW TW091102559A patent/TWI318201B/zh not_active IP Right Cessation
2003
- 2003-08-11 NO NO20033538A patent/NO328807B1/no not_active IP Right Cessation
- 2003-08-11 IL IL157340A patent/IL157340A/en active IP Right Grant
- 2003-09-04 US US10/654,756 patent/US20040044241A1/en not_active Abandoned
- 2003-09-11 ZA ZA2003/07116A patent/ZA200307116B/en unknown
2004
- 2004-11-10 US US10/985,292 patent/US7026508B2/en not_active Expired - Fee Related
2006
- 2006-01-18 US US11/334,223 patent/US7291347B2/en not_active Expired - Lifetime
2007
- 2007-08-20 US US11/841,638 patent/US20090018208A1/en not_active Abandoned
- 2007-10-22 CY CY20071101362T patent/CY1106952T1/el unknown
2009
- 2009-08-05 IL IL200255A patent/IL200255A/en active IP Right Grant
2010
- 2010-11-18 IL IL209444A patent/IL209444A/en active IP Right Grant
2011
- 2011-07-01 AR ARP110102372A patent/AR082076A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN100567253C (zh)	2009-12-09
CA2436668C (en)	2009-05-26
DK1360169T3 (da)	2007-11-26
MXPA03007043A (es)	2003-11-18
EP1864967A1 (en)	2007-12-12
CA2666611A1 (en)	2002-08-22
HUP0303128A2 (hu)	2003-12-29
HK1057885A1 (en)	2004-04-23
SI1360169T1 (sl)	2007-12-31
EA200300873A1 (ru)	2003-12-25
DE60221642T3 (de)	2017-10-26
CN101671260A (zh)	2010-03-17
IL157340A (en)	2010-04-15
EP1360169B2 (en)	2017-05-24
PL211788B1 (pl)	2012-06-29
US6673838B2 (en)	2004-01-06
NZ539791A (en)	2006-11-30
DE60221642T2 (de)	2008-05-21
ES2290281T3 (es)	2008-02-16
AU2002250058B2 (en)	2007-08-16
PE20020877A1 (es)	2002-11-12
US20090018208A1 (en)	2009-01-15
UY27175A1 (es)	2002-09-30
IL157340A0 (en)	2004-02-19
AR082076A2 (es)	2012-11-07
EA011451B1 (ru)	2009-04-28
ES2290281T5 (es)	2017-09-11
CN1501909A (zh)	2004-06-02
DE60221642D1 (en)	2007-09-20
PL364605A1 (en)	2004-12-13
US20040044241A1 (en)	2004-03-04
US20070037884A1 (en)	2007-02-15
WO2002064543A2 (en)	2002-08-22
ZA200307116B (en)	2005-02-23
JP2004529877A (ja)	2004-09-30
NO20033538L (no)	2003-08-11
EP2319826A1 (en)	2011-05-11
PA8539901A1 (es)	2005-05-10
IL209444A (en)	2012-10-31
PL396568A1 (pl)	2012-02-13
HN2002000030A (es)	2004-06-07
ATE369330T1 (de)	2007-08-15
HUP0303128A3 (en)	2008-03-28
EP1360169B1 (en)	2007-08-08
WO2002064543A3 (en)	2002-12-12
PL212943B1 (pl)	2012-12-31
KR100875610B1 (ko)	2008-12-26
IL209444A0 (en)	2011-07-31
IL200255A (en)	2010-12-30
TWI318201B (en)	2009-12-11
EP1360169A2 (en)	2003-11-12
US7026508B2 (en)	2006-04-11
US20050096479A1 (en)	2005-05-05
US7291347B2 (en)	2007-11-06
AR032671A1 (es)	2003-11-19
BR0207157A (pt)	2004-02-17
JP4220243B2 (ja)	2009-02-04
US20030045583A1 (en)	2003-03-06
NO20033538D0 (no)	2003-08-11
CA2436668A1 (en)	2002-08-22
PT1360169E (pt)	2007-10-29
CY1106952T1 (el)	2012-09-26
KR20030077614A (ko)	2003-10-01

Publication	Publication Date	Title
NO328807B1 (no)	2010-05-18	Nytt suksinatsalt av O-desmetyl-venlafaxine, fremgangsmate for fremstilling av disse, farmasoytisk preparat omfattende slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom
AU2002250058A1 (en)	2003-02-20	Novel succinate salt of O-desmethyl-venlafaxine
JP4445853B2 (ja)	2010-04-07	新規ｏ−デスメチルベンラファクシンギ酸塩
US20180071230A1 (en)	2018-03-15	Formulations, salts and polymorphs of transnorsertraline and uses thereof
HK1057885B (en)	2007-11-02	Succinate salt of o-desmethyl-venlafaxine
HK1111679A (en)	2008-08-15	Method for preparing o-desmethyl-venlafaxine
AU2007203410A1 (en)	2007-08-09	Novel succinate salt of o-desmethyl-venlafaxine

Legal Events

Date	Code	Title	Description
2022-03-07	MK1K	Patent expired